Incidence and outcomes of contralateral breast cancers

American Journal of Surgery

Volumn 195, Issue 5, 2008, Pages 645-650

  Quan, Glenda ^a   Pommier, SuEllen J ^a   Pommier, Rodney F ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Breast cancer; Contralateral; Metachronous; Synchronous

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER STAGING; CONTRALATERAL BREAST CANCER; FEMALE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; PROPHYLAXIS; STATISTICAL ANALYSIS; SURVIVAL TIME; UNITED STATES;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MASTECTOMY; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RISK ASSESSMENT; SEER PROGRAM; SURVIVAL ANALYSIS;

EID: 42049102783     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2008.01.007     Document Type: Article

References (14)

1. Hankey B.G., Curtis R.E., Naughton M.D., et al. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst 70 (1983) 797-804
2. Rosen P.P., Groshen S., Dinne D.W., et al. Contralateral breast carcinoma: an assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery 106 (1989) 904-910
3. Peralta E.A., Ellenhorn J.D., Wagman L.D., et al. Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer. Am J Surg 180 (2000) 439-445
4. Society of Surgical Oncology. SSO develops a position statement on prophylactic mastectomies. SSO News Summer 1 (1993) 10
5. Society of Surgical Oncology. Position statement on prophylactic mastectomy (2007). http://www.surgonc.org/default.aspx?id=179
6. McDonnell S.K., Schaid D.J., Myers J.L., et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. J Clin Oncol 19 (2001) 3938-3943
7. Babiera G.V., Lowry A.M., Davidson B.S., et al. The role of contralateral prophylactic mastectomy in invasive lobular carcinoma. Breast J 3 (1997) 2-6
8. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. Am J Statistics 53 (1958) 457-481
9. Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 17 regs limited-use, Nov 2006 Sub (1973-2004 varying), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2007, based on the November 2006 submission. Available from: www.seer.cancer.gov.
10. Carmichael A.R., Bendall S., Lockerbie L., et al. The long-term outcome of synchronous bilateral breast cancer is worse than metachronous or unilateral tumours. Eur J Surg Oncol 28 (2002) 388-391
11. Verkooijen H.M., Chatelain V., Fioretta G., et al. Survival after bilateral breast cancer: results from a population-based study. Breast Cancer Res Treat 105 (2007) 347-357
12. Vogel V.G., Costantino J.P., Wickerham D.L., et al. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 295 (2006) 2727-2741
13. Zion S.M., Slezak J.M., Sellers T.A., et al. Reoperations after prophylactic mastectomy with or without implant reconstruction. Cancer 98 (2003) 2152-2160
14. Frost M.H., Slezak J.M., Tran N.V., et al. Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. J Clin Oncol 23 (2005) 7849-7856